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Abstract: The acid-base equilibria of a novel hepatobiliary imaging agent, 2,4-diio-
do-6-methylphenylcarbamoylmethyl iminodiacetic acid (DIIODIDA) were studied.
The potentiometrically determined acidity constants of the second carboxylic group,
amino and amide groups were pK2 = 2.52  0.02; pK3 = 5.86  0.06 and pK4 = 10.9 
0.1. The determinations were performed at 25 ºC and an ionic strength of 0.1 mol/dm3
(NaCl). The acidity constants (pK1 = 1.3  0.4) corresponding to the first carboxylic
group was determined indirectly, on the basis of equilibrium constants obtained in a
heterogeneous system, at 25 ºC and an ionic strength 1 mol/dm3 (HCl, NaCl).
DIIODIDA was labeled with technetium-99m, and the influence of pH on the yield of
labeling was investigated. It was found that labeling within the pH range from 5.5 to
6.5 provided a radiopharmaceutical of high radiochemical purity (>98 %).
Keywords: iminodiacetic acid analogues, acidity constants, hepatobiliary agent,
technetium-99m.
INTRODUCTION
The analogues of iminodiacetic acid (IDA) labeled with technetium-99m are
used in nuclear hepatology for non-invasive and quantitative evaluation of numer-
ous hepatobiliary diseases related to bile formation and excretion.1 Functional im-
aging with suitable IDA analogues provides an objective basis for the choice of
therapy and critical evaluation of the efficiency of the chosen therapy. The biologi-
cal properties of complexes of 99mTc-IDA analogues depend on the blood bilirubin
level, because the transport of these radiopharmaceuticals across hepatocytes is a
carrier-mediated organic anion pathway, similar to the hepatic handling of biliru-
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bin. A high blood level of bilirubin leads to a decrease of both plasma and hepatic
clearance of 99mTc-IDA analogues, thus reducing the hepatic accumulation and
biliary excretion of these radiopharmaceuticals. Hence, hyperbilirubinemia repre-
sents the limiting factor in the application of 99mTc-IDA analogues as hepato-
biliary imaging agents. The structural and physicochemical relationships between
the lipophilic and polar groups in radiolabeled complexes play a key role in deter-
mining the affinity of the radiopharmaceuticals for binding to hepatic transport
proteins, the efficiency of their uptake by hepatocytes and the excretion rate. In-
creasing lipophilicity leads to a higher degree of resistance against the competitive
effects of bilirubin. Monohalogenic IDA analogues have diagnostic advantages
under hyperbilirubinemia conditions compared to non-halogenic ones.2–4
Biological studies on rats showed that the newly synthesized diiodo-IDA ana-
logue, 2,4-diiodo-6-methylphenylcarbamoylmethyl iminodiacetic acid (DIIODIDA)
has all the characterstics of a good hepatobiliary imaging agent and a greater toler-
ance to bilirubin than the presently used monoiodo-IDA analogues.5 The modifica-
tion procedure for the synthesis of DIIODIDA was performed in order to improve
the reaction yield.6 Its clinical application could be possible after kit preparation,
i.e., the determination of the best conditions for the preparation of the
99mTc-DIIODIDA complex. From a chemical point of view, DIIODIDA represents
a protolyte, with 4 potentially ionizable groups. Data on the acid-base equlibria of
DIIODIDA, i.e., the knowledge on the distribution of the equilibrium species, es-
pecially within the physiological pH range, is of great importance because it en-
ables the biological behaviour of the radiopharmaceutical to be understood and the
conditions for its labeling with 99mTc to be defined. This prompted us to determine
the acidity constants of DIIODIDA and, hence, define the conditions for the label-
ing this compound with technetium-99m, in order to obtain a radiopharmaceutical
of high radiochemical purity, which is a prerequisite for its clinical application.
EXPERIMENTAL
Apparatus
The pH values were determined on a pH meter PHM-82 with a combined GK 2401B electrode
(Radiometer, Copenhagen, Denmark). The electrode was calibrated using standard buffer solutions,
pH 4.01, 7.00 and 9.18 (Radiometer). The titrations were performed with a TTT-80 titrator and an
ABU-80 autoburette (Radiometer) (with an accuracy of 0.001 cm3), under a dynamic nitrogen atmo-
sphere. The temperature was kept constant within 0.1 ºC by using a thermostat HAAKE F3
(Karlsruhe, Germany).
The spectrophotometric measurements were performed on a GBC Cintra spectrophotometer
(GBC Scientific Equipment Pty Ltd., Dandenong, Australia).
The radioactivities were measured in a Gamma 333 scintillation counter (ICN Tracerlab Belgium).
Chemicals and reagents
The details on synthesis of DIIODIDA were reported previously.6 The purity of the DIIODIDA
was checked by thin layer chromatography, m.p. (224–225 ºC) and elemental analysis (deviations
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related to the calculated values was 0.10 %). The solution of Na 99mTcO4 was obtained from a
99Mo/99mTc-generator by eluating with 0.95 % NaCl (Vin~a Institute of Nuclear Sciences, Serbia
and Montenegro). All other chemicals (HCl, NaOH, NaCl and SnCl2
.H2O) used in this study were
analytical grade purity (Merck, Darmstadt, Germany). All solutions were prepared with double-dis-
tilled water.
Standardization of the HCl and NaOH solutions was performed potentiometrically. The NaOH
solution was standardized with potassium hydogenphthalate. The standardized NaOH solution was
used for the standardizacion of the HCl solution.
Determination of the constants K2, K3 and K4
The acidity constants K2, K3 and K4 were determined at a constant ionic strength of 0.1
mol/dm3 (NaCl) at 25.00.1 ºC. A solution of DIIODIDA (5.0-4 mol/dm3) was prepared in 0.1
mol/dm3 NaCl, and 25 cm3 aliquots were titrated with the standard HCl solution (0.1073 mol/dm3)
for the determination of the K2 constant, or with the standard NaOH solution (0.05688 mol/dm
3) for
the determination of the constants K3 and K4.
The value of n was calculated from the experimental data obtained by potentiometric titration
of DIIODIDA according to the equation:
n =
3c c c
c
NaOHDIIODIDA HCl
DIIODIDA
   
 
[H O ] [OH ]
3
(1)
where cDIIODIDA, cHCl and cNaOH correspond to the stoichiometric concentrations of DIIODIDA,
HCl and NaOH, respectively; H3O
+
 represents the equilibrium concentration of hydronium ion
obtained from the pH measurements; OH- is the concentration of hydroxide ions. The measured
pH values within the range from 2 to 12 were converted into pcH values according to the relation:
7
pcH = –log H3O
+
 = pH – A, where A represents a correction factor (0.05) obtained by titration of
the standard HCl solution with the standard NaOH solution at 25  0.1 ºC and ionic strength of 0.1
mol/dm3 (NaCl). The ionic product of water, pKw = 13.84 was determined by applying a previously
procedure reported.7
Determination of equilibrium constants in a heterogeneous system
Saturated solutions within the pcH range from 0 to 1 were obtained by treating an excess of
solid DIIODIDA with a standard HCl solution (1.062 mol/dm3), and a constant ionic strength of 1
mol/dm3 was maintained by adding NaCl. The pcH values were calculated according to the HCl con-
centrations. The samples were thermostated at 25.00.1 ºC with intensive stirring until equilibrium
was established (4 h). The two phases were separated by filtration. Aliquots of the filtrate were di-
luted and the final concentration of HCl was adjusted to 0.1 mol/dm3. The concentration of
DIIODIDA in those solutions was determined spectrophotometrically at the absorption maximum
of  = 227 nm against 0.1 mol/dm3 HCl as the blank. The Beer law had previously been verified for
the concentration range of DIIDIDA 310-6 – 310-5 mol/dm3.
Labeling with technetium-99m
Preparation of 99mTc-DIIODIDA. To a solution of 25 mg of DIIODIDA dissolved in 0.25 cm3
1 mol/dm3 NaOH, were added 3 cm3 of water and 0.02 cm3 of SnCl2
.H2O in 0.5 mol/dm
3 HCl (11
mg/cm3). The pH was adjusted to 5.5–7.5 by the addition of an appropriate volume of a HCl or
NaOH solution. To this solution, Na99mTcO4 (about 18 MBq) was added, making a final volume of 4
cm3. The radiochemical purity was determined after 15 min.5
Determination of the radiochemical purity 99mTc-DIIODIDA. The radiochemical purity and
the labeling yield were determined by instant thin-layer chromatography (ITLC).8
99mTc-DIIODIDA was separated from 99mTcO4
- using an ITLC SA strip with 2 mol/dm3 NaCl as the
mobile phase (Rf values of
99mTc-DIIODIDA and 99mTcO4
- were zero and 1.0, respectively). Hydro-
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lysed 99mTc and 99mTc-DIIODIDA were separated using an ITLC SG strip with 80 % CH3OH as the
mobile phase (Rf values of (
99mTc-DIIODIDA + 99mTcO4
-) and hydrolysed 99mTc were 0.85 and
zero, respectively).
RESULTS AND DISCUSSION
Determination of acidity constants
Considering that there are three acidic centers (two carboxylic groups and one
amide group) and one basic center (amino group) in the DIIODIDA molecule,
DIIODIDAundergoes complex acid-base equilibria in aqueous media (Scheme 1).
The neutral form of DIIODIDA (H3A) rearranges spontaneously to the zwit-
terion (H3A
), due to the protolysis of the first carboxylic group and proton accep-
tance of the amino group. The protolysis of the second carboxylic, amino and am-
ide groups afford H2A
–, HA2– and A3–, respectively. In more acidic media, the
H4A
+ form exists, as well. The corresponding equilibrium constants are defined as
follows:
K1 =
[H A ][H O ]
[H A ]
3 3
4
 

(2)
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Scheme 1.
K2 =
[H A ][H O ]
[H A ]
2 3
3
 

(3)
K3 =
[HA ][H O ]
[H A ]
2
3
2
 

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K4 =
[A ][H O ]
[HA ]
3
3
2
 

(5)
The acidity constants K2, K3 and K4 were determined potentiometrically by
application of the formation function method (n), i.e., the average number of
bound protons:9
n =
n n
n
n
n
[ ]
[ ]
H A
H A
1
0
	
	
(6)
(The charges in Eq. (6) are omitted for sake of simplicity).
The dependence of the experimentally determined function of formation (n) on
the pH value of the solution, (Eq. (1)), is shown in Fig. 1. The shape of the curve
shows that at pH > 2, DIIODIDAparticipates in three separate acid-base processes (n
within the ranges 3–2, 2–1 and 1–0). These three processes correspond to the K2, K3
and K4 constants, while the process corresponding to the K1 constant requires more
acidic media, i.e., pH values under 2.10,11 Taking into account the fact that the
acid-base processes corresponding to the K2, K3 and K4 constants are separate ones,
it was possible to determine their values independently of each other within the three
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Fig. 1. Dependence of the formation func-
tion (n) on pH.
different pH ranges, each characterized by the dominance of only one acid-base pair
species. The linear relationships that served to calculate the above constants are
listed in Table I. These linear relationships were obtained on the basis of the theoreti-
cally defined function of formation (n) for each individual pH range and the corre-
sponding equation for the acidity constant (Eqs. (3)–(5)). By using Eqs. (7), (8) and
(9) and the experimentally obtained n values within different pH ranges, the K2, K3
and K4 constants were calculated from the slopes of linear relationships (Fig. 2). The
obtained values of the constants are listed in Table II.
Bearing in mind that the acid-base process in which the first carboxylic group
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Fig. 2. Determination of DIIODIDA acidity constants K2, K3 and K4 by applying equations:
a) (7) K2, b) (8) K3, c) (9) K4.
of DIIODIDA participates occurs at pH values below 2, where DIIODIDA is only
slightly soluble in water, it was impossible to directly determine the constant K1
using pH-metrical titrations. Also, the classical spectrophotometric method could
not be applied since no significant changes in the absorption spectra of DIIODIDA
within the pH range from 0 to 4 were observed. Hence, the constant K1 was deter-
mined indirectly, on the basis of equilibrium constants obtained in a heterogeneous
system. In the solid state, DIIODIDA crystallized in its zwitterionic form, in a sim-
ilar way to HIDA (2,6-dimethylphenylcarbamoylmethyl iminodiacetic acid).11,12
Since the zwitter ion of DIIODIDA is the least soluble6,12 in aqueous solutions at
pH<1, the following equilibria are possible between the solid phase, (H3A
)s, and
the ions present in solution:
(H3A
)s  H3A

Ks0 = H3A


(10)
(H3A
)s + H3O
+
 H4A
+ + H2O Ks1 =
[H A ]
[H O ]
4
3


(11)
TABLE I. Survey of the equations for the potentiometric determination the acidity constants K2, K3
and K4 of DIIODIDA, obtained by linearizing the n–pH curve
Constant pH range Dominant
species
Formation function
(theoretically defined)
Linear
relationship
Equation
K2 2.3 – 3.5 H3A
; H2A
–
n =
3[H3A ] 2[H2A ]
[H3A ] [H2A ]






3
2
2
1




n
n
K
[ ]H3O
(7)
K3 4.7 – 6.8 H2A
–; HA2–
n =
2[H2A ] [HA
2
]
[H2A ] [HA
2
]






2
1
3
1




n
n
K
[ ]H3O
(8)
K4 9.2 – 11.0 HA
2–; A3–
n =
[HA
2
]
[HA ] [A
3
]



2
1
4
1



n
n
K
[ ]H3O
(9)
TABLE II. The equilibrium constants determined in homogeneous and heterogeneous systems of
DIIODIDA
Constants Value*
pK1 1.3  0.4
pK2 2.52  0.02
pK3 5.86  0.06
pK4 10.9  0.1
pKs0 5.0  0.4
pKs1 3.69  0.04
*Mean  standard deviation (n = 4)
Hence, the following relationship between the acidity constant K1 and the
equilibrium constants in a heterogeneous system exists:
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K1 =
K
K
s
s
0
1
(12)
The constants Ks0 and Ks1 were determined spectrophotometrically using the
method of solubilility.7 The solubility (S) of DIIODIDA at pH<1, where H3A
 and
H4A
+ forms are dominant, can be presented by the following expression:
S = H3A
 + H4A
+ (13)
From Eqs. (10), (11) and (13), a linear relationship was obtained:
S = Ks0 + Ks1 H3O
+

(14)
On the basis of the experimentally determined solubility of DIIODIDA in so-
lutions of HCl (pcH 0–1) and Eq. (14), by applying linear regression analysis, the
constants Ks0 (intercept) and Ks1 (slope) were calculated (Fig. 3). Based on the ob-
tained values for the constants in a heterogeneous system, the constant K1 was cal-
culated by applying Eq. (12).
The values of all the determined equilibrium constants of DIIODIDA are
given in Table II. The constants K2, K3 and K4 were determined at a constant ionic
strength of 0.1 mol/dm3 (NaCl), while K1 was determined at 1 mol/dm
3 (HCl and
NaCl). The large value of the standard deviation of pK1 could be explained by the
insufficiently reliable determination of the pK in a strongly acidic medium. The
obtained values for the acidity constants of DIIODIDA are in accordance to the
values for monohalogenic IDA analogues, 4-bromophenylcarbamoylmethyl imi-
nodiacetic acid (pK1 1.6, pK2 2.2, pK3 5.9)
13 and 4-iodo-2,6-dimethylphenylcar-
bamoylmethyl iminodiacetic acid (pK1 1.7, pK2 2.44, pK3 6.29, pK4 10.91).
11
On the basis of the determined acidity constants of DIIODIDA, the distribution
of the equilibrium species was calculated according to the following equations:

 
H A4
H
H H H



  
  
      
2
1
1
2
1
2
1
1
2
1
2
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1
K K
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2
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(15)
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Fig. 3. Solubility of DIIODIDA (S) as a
function of the hydronium ion (H3O
+) con-
centration.
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The corresponding distribution diagram of DIIODIDA is presented in Fig. 4.
Labeling with technetium-99m
TABLE III. The influence of pH on the labeling yield of 99mTc-DIIODIDA
pH 99mTc-DIIODIDA/% Hydrolysed 99mTc/% 99mTcO4
– /%
5.5 98.6 0.8 0.6
5.9 99.0 0.6 0.4
6.5 97.9 1.4 0.7
7.5 90.7 7.6 1.7
The labeling of IDA analogues with Tc-99m is a complex formation reaction.
Tc-IDA analogues applied as hepatobiliary imaging agents represent Tc(III) che-
lates with a 1:2 mole ratio, where each ligand is coordinated to the Tc(III)- center
through one imino nitrogen and two carboxylate oxygens.14–16 These compounds
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Fig. 4. The distribution of the ionic
forms of DIIODIDA as a function of
pcH.
could be prepared by reaction of the ligand with reduced Tc-pertechnetate or by
ligand substitution in a precursor, e.g. Tc(tu)6
3+ (hexakis(thiourea) techneti-
um(III) complex.17,18 During this substitution, decomposition of the precursor
Tc(tu)6
3+ and/or of the main product (Tc-complex) results in an increased forma-
tion of TcO2 as a radiochemical impurity (about 40 %).
16 According to the Euro-
pean Pharmacopoeia 4,19 not less than 95.0 per cent of the radioactivity must cor-
respond to technetium-99m complexed with IDA analogue. Bearing in mind all the
above mentioned facts, DIIODIDA was labeled with 99mTc-pertechnetate using
Sn(II) ions as the reductant within the pH range in which the dianion of DIIODIDA
(HA2–) is the dominant ionic species, as was determined from the distribution dia-
gram (Fig. 4). The influence of pH on the labeling yield of 99mTc-DIIODIDA is
presented in Table III. The results obtained by ITLC demonstrated that the
99mTc-DIIODIDA prepared within the pH range from 5.5 to 6.5 was of high
radiochemical purity (> 98 %), while a further increase of the pH led to a decrease
in the labeling yield. This may be explained by the fact that the reaction of this
complex formation is followed by the competitive hydrolysis reaction of techne-
tium and Sn(II) ions, resulting in the formation of various hydrolytic complexes as
radiochemical impurities, particularly at higher pH values.20
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KISELINE I OBELE@AVAWE TEHNECIJUMOM-99m
J. S. BRBORI]
1
, M. S. JOVANOVI]
2
, G. POPOVI]
1
, V. KAPETANOVI]
1
i S. VLADIMIROV
1
1
Farmaceutski fakultet, Univerzitet u Beogradu, Vojvode Stepe 450, p. pr. 146, 11000 Beograd i
2
Institut za nuklearne nauke „Vin~a”, Laboratorija za radioizotope, 11000 Beograd
Ispitane su kiselinsko-bazne ravnote`e novog hepatobilijarnog agensa, 2,4-di-
jod-6-metilfenilkarbamoilmetil iminodisir}etne kiseline. Kiselinske konstante
koje odgovaraju drugoj karboksilnoj grupi, amino i amidnoj grupi odre|ene su poten-
ciometrijski: pK2 = 2,52  0,02; pK3 = 5,86 0,06; pK4 = 10,9  0,1. Odre|ivawa su
izvedena na 25 ºC i pri konstantnoj jonskoj sili 0,1 mol/dm3 (NaCl). Kiselinska
konstanta prve karboksilne grupe (pK1 = 1,30,4) odre|ena je indirektno na osnovu
ravnote`nih konstanti odre|enih u heterogenom sistemu, na 25 ºC i jonskoj sili 1
mol/dm3 (HCl, NaCl). DIIODIDA je obele`ena tehnecijumom-99m i ispitan je uticaj pH
na prinos obele`avawa. Utvr|eno je da se obele`avawem u pH opsegu 5,5–6,5 dobija
radiofarmaceutik visoke radiohemijske ~isto}e (> 98 %).
(Primqeno 11. februara, revidirano 4. maja 2005)
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